6 February 2024 - Public reimbursement for Vascepa is now available in Ontario, Quebec, British Columbia, Saskatchewan, New Brunswick, Northwest Territories, ...
17 April 2023 - AbbVie today announced that Vraylat is now listed as an exception medication status on the list of ...
31 March 2023 - Mitsubishi Tanabe Pharma Canada is pleased to announce the company has entered into negotiations with the ...
7 February 2023 - Quebec public reimbursement coverage to facilitate and expand medication access for Parkinson’s patients in Quebec. ...
1 February 2023 - Medexus Pharmaceuticals wishes to inform investors that the company has reached an agreement with the provincial government ...
25 July 2022 - Reimbursement for Vascepa in Canada is now at more than 65% for publicly covered lives and private ...
13 July 2022 - Canada has seen a significant improvement in the number of Canadians eligible for some form of prescription ...
22 March 2022 - Canadian provincial public reimbursement now complete for Redesca with the addition of British Columbia. ...
26 August 2015 - CADTH has received notice of a pending submission from ApoPharma for deferiprone (Ferriprox) for patients with transfusional ...